3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2000

Study Completion Date

January 31, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

cisplatin

DRUG

paclitaxel

DRUG

triapine

Trial Locations (2)

10021

New York Presbyterian Hospital - Cornell Campus, New York

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

Sponsors
All Listed Sponsors
lead

Vion Pharmaceuticals

INDUSTRY

NCT00016874 - 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer | Biotech Hunter | Biotech Hunter